Share chart Aurobindo Pharma Limited
Extended chart
Simple chart
About Aurobindo Pharma Limited
Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally. more detailsMain settings
ISIN
INE406A01037
Industry
Pharmaceuticals
Sector
Health Care
Валюта
inr
Валюта отчета
inr
Див.доход ао
0.7306
Дивиденд ао
4.5
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 2.08 | 7 |
| P/BV | 2 | 7 |
| P/E | 18.84 | 7 |
Efficiency
| Title | Value | Grade |
| ROA | 7.47 | 2 |
| ROE | 11.2 | 4 |
| ROIC | 6.91 | 2 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0 | 0 |
| DSI | 0.7143 | 7.14 |
| Average dividend growth | -6.1 | 0 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | 1.58 | 7 |
| Debt/Ratio | 0.1401 | 10 |
| Debt/Equity | 0.5099 | 9 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 26.24 | 4 |
| Yield Ebitda, % | 2.24 | 1 |
| Yield EPS, % | 12.08 | 2 |
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 1 179.35 ₹ | 0 ₹ | 0 ₹ | 0.05 % | 0 % | 0 % |
| Week | 1 191.7 ₹ | 0 ₹ | 0 ₹ | -0.99 % | 0 % | 0 % |
| Month | 1 217.85 ₹ | 1 179.35 ₹ | 1 222.4 ₹ | -3.11 % | 0 % | 0 % |
| Three month | 1 081.4 ₹ | 1 056.5 ₹ | 1 257.6 ₹ | 9.11 % | 0 % | 0 % |
| Half a year | 1 223.95 ₹ | 1 051.75 ₹ | 1 351.4 ₹ | -3.59 % | 0 % | 0 % |
| Year | 1 195.65 ₹ | 1 051.75 ₹ | 1 574.95 ₹ | -1.31 % | 0 % | 0 % |
| 3 years | 529.6 ₹ | 403.9 ₹ | 1 574.95 ₹ | 122.8 % | 0 % | 0 % |
| 5 years | 643.15 ₹ | 403.9 ₹ | 1 574.95 ₹ | 83.46 % | 0 % | 0 % |
| 10 years | 0 ₹ | 294.35 ₹ | 1 574.95 ₹ | 0 % | 0 % | 0 % |
| Year to date | 1 255.4 ₹ | 1 051.75 ₹ | 1 348.65 ₹ | -6.01 % | 0 % | 0 % |
Company management
| Head | Job title | Payment | Year of birth |
| Mr. Mettu Madan Mohan Reddy | Whole-Time Director | 52.35M | 1960 (65 years) |
| Mr. Santhanam Subramanian | Chief Financial Officer | 21.06M | 1961 (64 years) |
| Mr. Sanjeev Indravadan Dani | COO & Head of Formulations | N/A | 1960 (65 years) |
| Dr. S. Vijaya Kumar | President of Technical | N/A | 1966 (59 years) |
| Mr. Arvind Bothra | Head of Investor Relations & Corporate Communications | N/A | |
| Mr. B. Adi Reddy | Compliance Officer & Company Secretary | 4.76M | |
| Mr. G. P. Prasad | Senior Vice President of Global Finance & Operations | N/A | |
| Dr. Sudhir Bimal Singhi | Head of Global Finance Operations | N/A | 1969 (56 years) |
| Mr. Kambam Nithyananda Reddy | Vice Chairman & MD | 1958 (67 years) | |
| Dr. Makkapati Satakarni B.E., M.B.A., Ph.D. | President of Biologics, CEO of Biologics, Vaccines and Peptid & Director | 1981 (44 years) |
About company
Address: India, Hyderabad, Galaxy Plot No. 1 - Open in google maps, Open in yandex maps
Website: https://www.aurobindo.com
Website: https://www.aurobindo.com
